Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis.

Creative Commons License

Gulbay B., Gurkan O. U., YILDIZ Ö., ÖNEN Z. P., Erkekol F. O., Baccioglu A., ...Daha Fazla

Respiratory medicine, cilt.100, sa.10, ss.1834-42, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 100 Sayı: 10
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1016/j.rmed.2006.01.014
  • Dergi Adı: Respiratory medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1834-42
  • Anahtar Kelimeler: side effects, antituberculosis (anti-TB) drugs, hepatotoxicity, ototoxicity, neuropsychiatric manifestations, hyperuricemia, RISK-FACTORS, LATENT TUBERCULOSIS, INDUCED HEPATOTOXICITY, PYRAZINAMIDE, RIFAMPIN, LIVER, CHEMOTHERAPY, INFECTION, PULMONARY
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: Side effects of the most commonly used primary antituberculosis (anti-TB) drugs may be mild as well as fatal. The aim of this study was to evaluate the side effects of and the risk factors for developing side effects against anti-TB drugs.